Tuberculosis_NN
and_CC
chronic_JJ
hepatitis_NN
B_NN
virus_NN
infection_NN
in_IN
Africans_NNS
and_CC
variation_NN
in_IN
the_DT
vitamin_NN
D_NN
receptor_NN
gene_NN
._.

The_DT
active_JJ
metabolite_NN
of_IN
vitamin_NN
D_NN
,_,
1,25_CD
dihydroxyvitamin_NN
D3_NN
,_,
is_VBZ
an_DT
important_JJ
immunoregulatory_JJ
hormone_NN
-LCB-_-LRB-
1_CD
-RCB-_-RRB-
._.

Its_PRP$
effects_NNS
are_VBP
exerted_VBN
by_IN
interaction_NN
with_IN
the_DT
vitamin_NN
D_NN
receptor_NN
,_,
which_WDT
is_VBZ
present_JJ
on_IN
human_JJ
monocytes_NNS
and_CC
activated_VBN
T_NN
and_CC
B_NN
lymphocytes_NNS
._.

Variation_NN
in_IN
the_DT
vitamin_NN
D_NN
receptor_NN
gene_NN
was_VBD
typed_VBN
in_IN
2015_CD
subjects_NNS
from_IN
large_JJ
case-control_JJ
studies_NNS
of_IN
three_CD
major_JJ
infectious_JJ
diseases_NNS
:_:
tuberculosis_NN
,_,
malaria_NN
,_,
and_CC
hepatitis_NN
B_NN
virus_NN
._.

Homozygotes_NNS
for_IN
a_DT
polymorphism_NN
at_IN
codon_NN
352_CD
-LRB-_-LRB-
genotype_NN
tt_NN
-RRB-_-RRB-
were_VBD
significantly_RB
underrepresented_JJ
among_IN
those_DT
with_IN
tuberculosis_NN
-LRB-_-LRB-
chi2_NN
=_JJ
6.22_CD
,_,
1_CD
df_NN
,_,
P_NN
=_JJ
.01_CD
-RRB-_-RRB-
and_CC
persistent_JJ
hepatitis_NN
B_NN
infection_NN
-LRB-_-LRB-
chi2_NN
=_JJ
6.25_CD
,_,
1_CD
df_NN
,_,
P_NN
=_JJ
.01_CD
-RRB-_-RRB-
but_CC
not_RB
in_IN
subjects_NNS
with_IN
clinical_JJ
malaria_NN
compared_VBN
with_IN
the_DT
other_JJ
genotypes_NNS
._.

Therefore_RB
,_,
this_DT
genetic_JJ
variant_NN
,_,
which_WDT
predisposes_VBZ
to_TO
low_JJ
bone_NN
mineral_JJ
density_NN
in_IN
many_JJ
populations_NNS
,_,
may_MD
confer_VB
resistance_NN
to_TO
certain_JJ
infectious_JJ
diseases_NNS
._.

